(S)-tert-Butyl 2-methylpiperidine-1-carboxylate

Catalog No. :
ACBEQN142
CAS No. :
183903-99-3
Molecular Formula :
C11H21NO2
Molecular Weight :
199.29

IUPAC Name:tert-butyl (S)-2-methylpiperidine-1-carboxylate

(S)-tert-Butyl 2-methylpiperidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg96%$176.00Login to see priceInquiryInquiry
250mg96%$254.00Login to see priceInquiryInquiry
1g96%$644.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-tert-Butyl 2-methylpiperidine-1-carboxylate
IUPAC Nametert-butyl (S)-2-methylpiperidine-1-carboxylate
MDL No.MFCD06799025
Molecular FormulaC11H21NO2
Molecular Weight199.29
SMILESO=C(N1[C@@H](C)CCCC1)OC(C)(C)C
InChI KeyDHJKRRZIUOQEFW-VIFPVBQESA-N
Synonym(S)-(+)-N-TBOC-2-METHYLPIPERIDINE;(S)-(+)-N-TERT-(BUTOXYCARBONYL)-2-METHYLPIPERIDINE;S-(+)-N-TERT-(BUTOXYCARBONYL);(S)-(+)-N-(Boc)-2-Methylpiperidine;tert-Butyl (S)-2-methylpiperidine-1-carboxylate;1-Piperidinecarboxylic acid, 2-methyl-, 1,1-dimethylethyl ester, (2S)-;tert-butyl (2S)-2-methylpiperidine-1-carboxylate;(S)-(+)-N-(Boc)-2-methylpiperidine
CAS No.183903-99-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACBEQN142 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACMKWR148 route compound structure diagram
    ACMKWR148205526-61-0 In Stock
  4. Then
  5. ACBEQN142 route product structure diagram
    ACBEQN142183903-99-3
Inquiry

2. ACBEQN142 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBEQN142 route product structure diagram
    ACBEQN142183903-99-3
Inquiry

Comments (0)